TSC loss distorts DNA replication programme and sensitises cells to genotoxic stress

Oncotarget. 2016 Dec 20;7(51):85365-85380. doi: 10.18632/oncotarget.13378.

Abstract

Tuberous Sclerosis (TSC) is characterized by exorbitant mTORC1 signalling and manifests as non-malignant, apoptosis-prone neoplasia. Previous reports have shown that TSC-/- cells are highly susceptible to mild, innocuous doses of genotoxic stress, which drive TSC-/- cells into apoptotic death. It has been argued that this hypersensitivity to stress derives from a metabolic/energetic shortfall in TSC-/- cells, but how metabolic dysregulation affects the DNA damage response and cell cycle alterations in TSC-/- cells exposed to genotoxic stress is not understood. We report here the occurrence of futile checkpoint responses and an unusual type of replicative stress (RS) in TSC1-/- fibroblasts exposed to low-dose genotoxins. This RS is characterized by elevated nucleotide incorporation rates despite only modest origin over-firing. Strikingly, an increased propensity for asymmetric fork progression and profuse chromosomal aberrations upon mild DNA damage confirmed that TSC loss indeed proved detrimental to stress adaptation. We conclude that low stress tolerance of TSC-/- cells manifests at the level of DNA replication control, imposing strong negative selection on genomic instability that could in turn detain TSC-mutant tumours benign.

Keywords: adaptive responses; genotoxic stress; mTORC1; replication stress; tuberous sclerosis.

MeSH terms

  • Animals
  • Cell Cycle / drug effects
  • Cell Death / drug effects
  • Cells, Cultured
  • Chromosome Aberrations / chemically induced
  • DNA Damage*
  • DNA Replication*
  • Dose-Response Relationship, Drug
  • Doxorubicin / toxicity*
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Genomic Instability / drug effects
  • Hydroxyurea / toxicity*
  • Mice, Knockout
  • RNA Interference
  • Sirolimus / toxicity*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / metabolism
  • Time Factors
  • Transfection
  • Tuberous Sclerosis Complex 1 Protein
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Protein p53 / deficiency
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Proteins / deficiency*
  • Tumor Suppressor Proteins / genetics

Substances

  • Tsc1 protein, mouse
  • Tuberous Sclerosis Complex 1 Protein
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Doxorubicin
  • mTOR protein, mouse
  • TOR Serine-Threonine Kinases
  • Sirolimus
  • Hydroxyurea